Tango Therapeutics Inc is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TNGX is expected to report earnings to fall 3.97% to -34 cents per share on August 06
Q2'25
Est.
$-0.35
Q1'25
Est.
$-0.36
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.11
The last earnings report on May 12 showed earnings per share of -36 cents, meeting the estimate of -36 cents. With 2.94M shares outstanding, the current market capitalization sits at 381.01M.